Eiko Lifesciences (BOM:540204) Total Stockholders Equity : ₹567.9 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Eiko Lifesciences Total Stockholders Equity?

Eiko Lifesciences's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₹567.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Eiko Lifesciences's Book Value per Share for the quarter that ended in Mar. 2025 was ₹40.56. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Eiko Lifesciences's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.05.

Eiko Lifesciences Total Stockholders Equity Historical Data

The historical data trend for Eiko Lifesciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eiko Lifesciences Total Stockholders Equity Chart

Eiko Lifesciences Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Stockholders Equity

Get a 7-Day Free Trial

125.26

286.30

294.22

506.78

567.89

Eiko Lifesciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															506.78	-	513.31	-	567.89

Eiko Lifesciences (BOM:540204) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Eiko Lifesciences's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(567.886	-	0)	/	14.000
	=	40.56

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Eiko Lifesciences's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(7.551	+	20.083)	/	567.886
	=	0.05

Eiko Lifesciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Eiko Lifesciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Eiko Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Eiko Lifesciences Ltd (BOM:540204) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

604, Centrum, Wagle Estate, Opposite TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane, MH, IND, 400604

Website

https://www.eikolifesciences.com

Eiko Lifesciences Ltd is a manufacturer of specialty and fine chemicals. The company mainly engaged in one segment that is in the field of Specialty and fine chemicals, and their related products.

Eiko Lifesciences Headlines

No Headlines